Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Resveratrol Partners alleges false claims

This article was originally published in The Tan Sheet

Executive Summary

The maker of the resveratrol supplement Longevinex sues the reported owner of the Web site ResveratrolBenefits.com, identified as Jon Mayne, for allegedly making false and misleading statements about Longevinex. Mayne, which may be an alias, lists on his Web site Longevinex for more than twice the actual sale price, says it is "less effective" than other products and claims "there are no truly free trials of Longevinex available," according to Sept. 9 release from Resveratrol Partners, which filed the suit in Los Angeles federal court. The Las Vegas-based supplement maker notes Mayne's address is a United Parcel Service Store in San Francisco. It also maintains that ResveratrolBenefits.com links to Web sites that offer free products to consumers, but then charge their credit cards for unordered products. FTC is investigating these types of ads (1"The Tan Sheet" March 30, 2009)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103327

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel